Definium Therapeutics (DFTX) Cost of Revenue (2019 - 2021)
Definium Therapeutics (DFTX) reported Cost of Revenue of $294000.0 for Q2 2021, down 57.14% year-over-year from $686000.0 in Q2 2020, and down 61.82% on a QoQ basis from $770000.0 in Q1 2021.
Definium Therapeutics (DFTX) has 3 years of Cost of Revenue data on file, last reported at $294000.0 in Q2 2021.
- Quarterly Cost of Revenue fell 57.14% year-over-year to $294000.0 in Q2 2021, while the trailing twelve-month figure through Jun 2021 was $294000.0 (down 57.14% YoY) and the FY2020 annual result came in at $782000.0, up 322.7% from the prior year.
- Cost of Revenue eased to $294000.0 in Q2 2021 per DFTX's latest filing, from $770000.0 in the prior quarter.
- Across five years, Cost of Revenue topped out at $782000.0 in Q4 2020 and bottomed at $185000.0 in Q4 2019.
- The 3-year median for Cost of Revenue is $550000.0 (2020), against an average of $511285.7.
- The widest annual swing landed in 2020, when Cost of Revenue soared 322.7%; it then sank 57.14% in 2021.
- Tracing DFTX's Cost of Revenue over 3 years: stood at $185000.0 in 2019, then soared by 322.7% to $782000.0 in 2020, then slumped by 62.4% to $294000.0 in 2021.
- Per Business Quant, the three latest DFTX Cost of Revenue figures stand at $294000.0 (Q2 2021), $770000.0 (Q1 2021), and $782000.0 (Q4 2020).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 64.20 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 392.80 Mn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 296.00 Mn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 207.52 Mn |
| 10 | Definium Therapeutics | 2.42 Bn | 2.06 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 294,000.00 |
| Jun 30, 2021 | 294,000.00 |
| Mar 31, 2021 | 770,000.00 |
| Mar 31, 2021 | 770,000.00 |
| Dec 31, 2020 | 782,000.00 |
| Dec 31, 2020 | 782,000.00 |
| Sep 30, 2020 | 550,000.00 |
| Sep 30, 2020 | 550,000.00 |
| Jun 30, 2020 | 686,000.00 |
| Jun 30, 2020 | 686,000.00 |
| Mar 31, 2020 | 312,000.00 |
| Mar 31, 2020 | 312,000.00 |
| Dec 31, 2019 | 185,000.00 |
| Dec 31, 2019 | 185,000.00 |